Insulin Pumps Market to Expand at 15.50 % CAGR During Forecast

Pune, India, 2023, MRFR Press Release/- Market Research Future has Published a Cooked Research Report on the Global Insulin Pump Market.

Market Dynamics

Global Insulin Pumps Market is projected to grow from USD 4.73 Billion in 2023 to USD 14.99 Billion by 2032, exhibiting a CAGR of 15.50% during the forecast period (2023 - 2032).

The global market for insulin pumps is expected to expand as a result of the devices' ease of use. The convenience of insulin pumps, the growing popularity of fast food, and the widespread acceptance of couch potato culture are all factors that could drive sales. Demand for insulin devices, such as insulin pumps, is expected to grow as the number of people diagnosed with diabetes continues to rise.

Market growth could be encouraged by factors including rising rates of development and obesity and new government programs designed to boost sales. With an ever-increasing number of people being diagnosed with and treated for type 2 diabetes, there is a pressing need for novel approaches to care. The shift from painful MDI to painless and alternative treatments, as well as the increasing number of insulin-dependent patients with type 2 diabetes, are further driving demand for these pumps.

Artificial intelligence (AI) and other intelligent technologies have had a rapid influence on the healthcare IT industry and are making steady development in the management of diabetes at the present time. The increasing number of people with type 2 diabetes who rely on insulin pumps has created a need for more advanced pumps. Increased government backing, however, may soon be able to fund the industry's future expansion. An increase in insulin prices and unfavorable insurance policies are both likely to slow down the evaluation process.

Segmental Analysis

Traditional insulin pumps and disposable insulin pumps are the two types of insulin pumps available in the global market.

Infusion sets, insulin reservoirs, and infusion set insertion devices are the three main categories of accessories in the global insulin pump industry.

Type I diabetes and Type II diabetes are the two types of diabetes that the global market is divided into.

Home care, hospital & clinics, and laboratory are the three end-user segments in the worldwide insulin pumps market.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Insulin Pump Market Research Report

Regional Overview

North America is the largest market for insulin pumps in the world, according to a report by MRFR. Growth in the North American insulin pump market can be attributed to the region's well-developed healthcare system, cutting-edge medical facilities, and the widespread uptake of novel therapies. The concentration of so many world-class competitors in one area fuels creativity and innovation. Availability of trained medical personnel, an abundance of suitable products, and a sizable consumer base are also factors in the growth of this market. In 2016, North America dominated the global insulin pump market and earned the most revenue.

As a result of rising healthcare spending and a rapidly expanding healthcare industry, it is anticipated that Asia-Pacific would be the fastest-growing region in the global insulin pumps market. The healthcare industry is thriving as government funding grows. These are two crucial factors that can propel the APAC market forward. The increasing prevalence due to an aging population is also expected to be a major factor propelling the market forward over the forecast period.

Europe is expected to become a significant player in the global insulin pump industry. If businesses want to fuel economic expansion, they need to devote more resources to constant innovation. The healthcare industry and related industries are undergoing transformations to bring the best effective products to consumers. The markets in the UK and Germany are expected to play a significant role in the growth of the insulin pump industry.

Competitive Dynamics

The notable players of the market are Insulet Corporation, Dickinson and Company, Hoffmann-La Roche AG, Abbott Laboratories, Braun Melsungen AG, Medtronics, Becton, Sanofi.